Vinicor-D 25mg 10 Tablets

babies: not applicable. lactating mothers: nil.
pregnancy: it is contraindicated in pregnancy. seek a doctor's advice.
driving: these tablets may decrease alertness, affects vision, and may cause dizziness and sleep. do not drive if these symptoms occur.
alcohol: you must follow caution while consuming alcohol with this tablet. seek doctor's advice. liver: chlorthalidone and metoprolol succinate tablets should be used in caution with patients suffering from liver disease.
you may require dosage adjustment and regular monitoring of liver function. seek doctor advice before using this medication.
kidney: chlorthalidone and metoprolol succinate tablets should be used in caution with patients suffering from kidney disease. you may require dosage adjustment and regular monitoring of kidney function.
seek doctor advice before using this medication. .

Constipation Nausea Diarrhea Fatigue Headache Dizziness Slow heart rate Increased blood uric acid Decreased potassium level in blood Glucose intolerance Altered blood lipid level Cold extremities Decreased magnesium level in blood Increased calcium level in blood.

VINICOR-D tablets work by blocking the effects of some chemicals on your heart and blood vessels. it slows down your heart rate and helps the heartbeat with less force..

If you miss a dose, take VINICOR-D as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• VINICOR-D tablets should take with or without food. • chlorthalidone and metoprolol succinate tablet is a combination of two blood pressure-lowering medications.
it is used to treat high blood pressure. • do not stop taking this tablet suddenly as it can cause your blood pressure to rise suddenly, thereby increasing the risk of heart attack and stroke. • consume plenty of water and keep yourself well-hydrated while on medication.

serious • chlorthalidone + desmopressin: concurrent use leads to increased risk of hyponatremia. • chlorthalidone + aceclofenac: concurrent use may lead to result in reduced diuretic effectiveness and possible nephrotoxicity.
• chlorthalidone + dapagliflozin: concurrent use leads to result in increased hyperglycemia risk; increased insulin requirement. • metoprolol succinate + diltiazem: concurrent use of both drugs may result in an increased risk of hypotension, bradycardia, av conduction disturbances.
• metoprolol succinate + levalbuterol: concurrent use leads to result in decreased efficacy of levalbuterol. monitor closely • chlorthalidone + levalbuterol: concurrent use leads to result in ecg changes or hypokalemia • chlorthalidone + enalapril: concurrent use leads to result in the reduction of blood pressure.
• metoprolol succinate + salmeterol: concurrent use of both drugs may decrease the efficacy of salmeterol..